Table 3:
Prevalence and Incidence of Sexually Transmitted Infections, by HIV Status and Study Time Point
| HIV-Negative | ||||||
|---|---|---|---|---|---|---|
| Chlamydiaa | Gonorrheaa | Syphilis | ||||
| Prevalence | Incidence | Prevalence | Incidence | Prevalence | Incidence | |
| Baseline (nHIV− = 167) | 13 (7.8%) | - | 8 (4.8%) | - | 7 (4.2%) | - |
| 3-Month Assessment (nHIV− = 146) | 2 (1.4%) | 0 (0.0%) | 2 (1.4%) | 4 (2.7%) | 6 (4.1%) | 2 (1.4%) |
| 6-Month Assessment (nHIV− = 143) | 1 (0.7%) | 1 (0.7%) | 0 (0.0%) | 3 (2.1%) | 7 (4.9%) | 1 (0.7%) |
| 9-Month Assessment (nHIV− = 150) | 4 (2.7%) | 2 (1.3%) | 0 (0.0%) | 2 (1.3%) | 7 (4.7%) | 0 (0.0%) |
| HIV-Positive | ||||||
| Baseline (nHIV+ = 119) | 8 (6.7%) | - | 10 (8.4%) | - | 31 (26.1%) | - |
| 3-Month Assessment (nHIV+ = 105) | 1 (1.0%) | 4 (3.8%) | 2 (1.9%) | 4 (3.8%) | 22 (21.0%) | 8 (7.6%) |
| 6-Month Assessment (nHIV+ = 97) | 1 (1.0%) | 8 (8.2%) | 1 (1.0%) | 5 (5.2%) | 25 (25.8%) | 2 (2.1%) |
| 9-Month Assessment (nHIV+ = 105) | 3 (2.9%) | 7 (6.7%) | 4 (3.8%) | 6 (5.7%) | 23 (21.9%) | 12 (11.4%) |
| Total | 21 | 22 | 18 | 24 | 38 | 25 |
| Total Cases | 43 | 42 | 63 | |||
a
Rectal, Oral, or Genital